Medicines safeguard clause: 20% of the contribution allocated by place of production

Article 32 of the 2026 Social Security Financing Act changes how the safeguard clause contribution is shared among companies (II of Article L. 138-12 of the Social Security Code): the share allocated by the amount reimbursed by health insurance falls from 70% to 50%, and 20% is allocated according to the share of the company's medicines produced in the European Union, with a coefficient from 4 (20% or less produced in the EU) to 0 (more than 80%).